Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia
- PMID: 15292665
- DOI: 10.1159/000079102
Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia
Abstract
Most antipsychotic drugs act on the forebrain by blocking dopamine receptors. In rodents, the M5 muscarinic receptor (CHRM5) is important for prolonged dopamine release. We typed polymorphisms in CHRM5 and alpha7-nicotinic receptor (CHRNA7) genes on 15q13 in 82 Canadian families having at least 1 schizophrenic patient. Using the Family-Based Association Test, we performed haplotype analysis of the 2 loci and found biased transmission in schizophrenia (z = -2.651, p = 0.008). In the families tested, the 2 cholinergic genes interacted to affect schizophrenia in combination, while neither was sufficiently alone to confer susceptibility. Our present study provided the first line of direct evidence suggesting that the CHRM5 gene combined with the CHRNA7 gene may be linked to schizophrenia.
Similar articles
-
Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7).Am J Med Genet. 2001 Jan 8;105(1):20-2. Am J Med Genet. 2001. PMID: 11424985
-
Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia.Acta Psychiatr Scand. 2006 Sep;114(3):211-5. doi: 10.1111/j.1600-0447.2006.00785.x. Acta Psychiatr Scand. 2006. PMID: 16889592
-
Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia.Exp Brain Res. 2006 Sep;174(2):292-6. doi: 10.1007/s00221-006-0458-y. Epub 2006 Apr 25. Exp Brain Res. 2006. PMID: 16636791
-
Genetics of chromosome 15q13-q14 in schizophrenia.Biol Psychiatry. 2006 Jul 15;60(2):115-22. doi: 10.1016/j.biopsych.2006.03.054. Biol Psychiatry. 2006. PMID: 16843094 Review.
-
Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disorders.Clin Neuropharmacol. 2011 Nov-Dec;34(6):203-5. doi: 10.1097/WNF.0b013e31823a1247. Clin Neuropharmacol. 2011. PMID: 22094647 Review.
Cited by
-
The antipsychotic potential of muscarinic allosteric modulation.Drug News Perspect. 2010 May;23(4):229-40. doi: 10.1358/dnp.2010.23.4.1416977. Drug News Perspect. 2010. PMID: 20520852 Free PMC article. Review.
-
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia.Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10978-83. doi: 10.1073/pnas.0800567105. Epub 2008 Aug 4. Proc Natl Acad Sci U S A. 2008. PMID: 18678919 Free PMC article.
-
Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets.CNS Neurosci Ther. 2012 May;18(5):369-79. doi: 10.1111/j.1755-5949.2011.00249.x. Epub 2011 Feb 26. CNS Neurosci Ther. 2012. PMID: 22070219 Free PMC article. Review.
-
Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.Sci Rep. 2023 Oct 21;13(1):18022. doi: 10.1038/s41598-023-45347-1. Sci Rep. 2023. PMID: 37865690 Free PMC article.
-
5-HT2C receptor and MAO-A interaction analysis: no association with suicidal behaviour in bipolar patients.Eur Arch Psychiatry Clin Neurosci. 2008 Oct;258(7):428-33. doi: 10.1007/s00406-008-0815-x. Epub 2008 May 26. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18504633
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical